According to the American Cancer Society, over 133,000 new cases of colorectal cancer are diagnosed each year in the United States. It is a common form of cancer in both men and women — almost 7 percent of Americans will probably develop the disease at some time in their lives. The good news is that colorectal cancer can be treated effectively, especially when detected early, and the latest technological developments have increased the cure rates.

The USC/Norris Colorectal Cancer Program offers a multidisciplinary team of physicians and scientists dedicated to colorectal cancer research and the comprehensive delivery of state-of-the-art patient care. Treatment options include surgery, radiation therapy and chemotherapy. Surgery is the most common treatment for all stages of colorectal cancer. In cases where the cancer is found fairly early, surgical removal of the tumor leads to a cure in 75 percent of patients.

Comprehensive care is provided by USC physicians in both in-patient and out-patient settings. All of the physicians on staff at both the Center and Hospital are on the faculty of the Keck School of Medicine of USC. The team includes experts from eight specialties offering aspects of colorectal cancer care from prevention, screening and risk assessment, diagnostic work-up, and treatment for early, advanced and metastatic colorectal cancer.